openPR Logo
Press release

Investigation announced for Investors in shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM)

07-29-2019 09:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Oasmia Pharmaceutical AB (publ) (OASM) shares over potential securities laws violations by Oasmi

An investigation for investors in Oasmia Pharmaceutical AB (publ) (OASM) shares over potential securities laws violations by Oasmi

An investigation was announced on behalf of investors of Oasmia Pharmaceutical AB (publ) (OASM) shares over potential securities laws violations by Oasmia Pharmaceutical AB.

Investors who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Oasmia Pharmaceutical AB (publ) (OASM) concerning whether a series of statements by Oasmia Pharmaceutical AB (publ) (OASM regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Sweden based Oasmia Pharmaceutical AB develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. On July 9, 2019, post-market, Oasmia reported that it had terminated its “engagement and cooperation” with former executive chairman Julian Aleksov without further pay, following a tax audit that revealed missing funds connected to suspicious transactions between Oasmia and companies controlled by Aleksov and his former father-in-law. Shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) declined from $5.06 per share in November 2018 to as low as $1.78 per share on July 11, 2019.

On July 26, 2019, NASDAQ: OASM shares closed at $1.7487

Those who purchased shares of Oasmia Pharmaceutical AB (publ) (OASM) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM) here

News-ID: 1813843 • Views: 194

More Releases from Shareholders Foundation

Investigation announced for NYSE: COF Investors over possible Wrongdoing at Capi …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Capital One Financial Corporation. Investors who are current long term investors in Capital One Financial Corporation (NYSE: COF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: COF stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Acadia Healthcare Company Inc …
An investigation was announced for investors in shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning potential breaches of fiduciary duties by certain directors at Acadia Healthcare Company Inc. Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) and currently hold any of those NASDAQ: ACHC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Investigation for Investors in shares of PlayAGS, Inc. (NYSE: AGS) announced
An investigation was announced concerning potential securities laws violations by PlayAGS, Inc. in connection with certain financial statements. Investors who purchased shares of PlayAGS, Inc. (NYSE: AGS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of PlayAGS, Inc. (NYSE: AGS) concerning whether a series of statements
Lawsuit filed for Investors in shares of Spirit AeroSystems Holdings, Inc. (NYSE …
An investor, who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR), filed a lawsuit over alleged violations of Federal Securities Laws by Spirit AeroSystems Holdings, Inc. Investors who purchased shares of Spirit AeroSystems Holdings, Inc. (NYSE: SPR) have certain options and for certain investors are short and strict deadlines running. Deadline: April 10, 2020. NYSE: SPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases